Lemaitre Vascular (LMAT) Current Deferred Revenue (2018 - 2019)
Lemaitre Vascular (LMAT) posted quarterly Current Deferred Revenue of $188000.0 for Q2 2019, down 80.23% year-over-year from $951000.0 in Q2 2018, and down 48.91% quarter-over-quarter from $368000.0 in Q1 2019.
Lemaitre Vascular (LMAT) Current Deferred Revenue (2018 - 2019) Analysis & Trends
Lemaitre Vascular (LMAT) has reported Current Deferred Revenue for 2 consecutive years, with $188000.0 the latest figure, recorded in Q2 2019.
- In Q2 2019, Current Deferred Revenue fell 80.23% year-over-year to $188000.0; the TTM figure through Jun 2019 stood at $188000.0 (down 80.23% YoY), while the FY2018 annual figure was $552000.0, changed N/A from the prior year.
- Current Deferred Revenue eased to $188000.0 in Q2 2019 per LMAT's latest filing, from $368000.0 in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $951000.0 in Q2 2018 and bottomed at $188000.0 in Q2 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Lemaitre Vascular | 1.88 Bn | 1.50 Bn | 50.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | 188,000.00 |
| Mar 31, 2019 | 368,000.00 |
| Dec 31, 2018 | 552,000.00 |
| Sep 30, 2018 | 752,000.00 |
| Jun 30, 2018 | 951,000.00 |